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bovine‐derived	products	 are	 antigenic	 in	humans	who	 receive	bioprosthetic	heart	
valves	 (BHVs)	or	 those	 that	 suffer	 from	 red	meat	 syndrome.	Using	programmable	





cloned	 embryos	 that	 were	 implanted	 in	 surrogate	 recipient	 heifers.	 Fifty‐three	




colylneuraminic	 acid	 (Neu5Gc)	 whose	 synthesis	 are	 catalysed	 by	
α(1,3)	 galactosyltransferase	 (encoded	 by	 the	 GGTA1	 gene)1,2 and 
CMP‐Neu5Gc	hydroxylase	(encoded	by	the	CMAH	gene)3‐5 respec‐
tively.	These	have	been	 identified	 as	major	 antigens	 in	 xenotrans‐
plantation	studies	or	retrospective	clinical	findings3.	Pigs	that	carry	
mutations	 in	 both	 genes,	 and	 therefore	 lack	 these	 xenoantigens,	
have been generated.6	Moreover,	porcine	kidneys	 lacking	αGal	are	
not hyperacutely rejected.7 It is also expected that such tissues will 
be	 less	 immunogenic	 for	patients	being	 implanted	with	animal‐de‐
rived tissues engineered to lack both antigens.
One	of	the	major	clinical	applications	of	xenogenic	tissues	is	for	
the	manufacturing	of	bioprosthetic	heart	valves	 (BHVs),	and	 it	has	
been shown that such tissues carry the same xenoantigens despite 
the	glutaraldehyde	treatments	used	in	the	manufacturing	process8,9. 







undergo	SVD	much	earlier.11 It is hypothesized that among various 
metabolic	causes,	SVD	is	also	immune‐mediated	since	both	αGal8,12 
and	Neu5Gc9,13	are	still	present	on	the	BHV	used	in	the	clinic.
After	BHV	 replacement,	 there	 is	 an	 increase	of	 anti‐αGal	anti‐
bodies14,15 and it has been reported in an experimental context that 
implantation	of	BHV	 from	αGal‐knockout	pigs	 into	primates	 is	 as‐
sociated	with	 a	 reduced	 anti‐αGal	 immune	 response.16	Moreover,	
valves	from	αGal/Neu5Gc‐deficient	pigs	further	reduce	human	IgM/
IgG	binding	when	compared	to	BHV	from	wild‐type	pigs17.	A	similar	
situation	 is	 likely	to	occur	whether	bovine	double	knockout	 (DKO)	
tissue	would	be	used.	Seventy	per	cent	of	the	BHV	currently	used	









is	 not	 synthesized	by	humans,	 but	 it	 can	be	 incorporated	 through	
the	 diet	 and	 found	 in	minute	 amounts	 in	 endothelial	 or	 epithelial	
cells	 of	 various	 tissues,	 likely	 contributing	 to	 inflammation‐related	
diseases.20,21	Furthermore,	cattle	can	be	used	as	a	 “bioreactor”	 to	
produce	 bioactive	molecules	 for	 nutraceuticals	 or	 biomedical	 use,	
including	r‐human	lactoferrin22	in	bovine	milk.	However,	the	result‐
ing	 product	 differs	 from	 the	 human	 one	 because	 of	 the	 different	
glycosylation pattern.23	Similarly,	partially	“humanized”	antibodies24 
produced	 in	 cattle	 for	 various	 purposes	 still	 display	 Neu5Gc	 epi‐
topes25,26	 that	might	be	 the	 target	of	an	 immune	 response	by	 the	
host	with	clinically	relevant	side	effects.
The	 scope	of	 the	 present	work	was	 to	 generate	 cattle	KO	 for	
both αGal	and	Neu5Gc	antigens	using	a	genome	editing	approach.27 
A	stillborn	calf	KO	for	αGal	has	been	reported,28	but	to	the	best	of	
our	 knowledge,	 this	 work	 has	 not	 progressed	 further.	 Availability	
of	DKO	cattle	 line	offers	 the	opportunity	 to	explore	 the	potential	
of	 such	 animals	 to	 provide	 low	 immunogenic	 cattle‐derived	 prod‐
ucts	for	clinical	purposes	as	well	as	for	the	food	industry	and	human	
consumption.
2  | MATERIAL S AND METHODS
2.1 | Animal experiments and source of animals





and	 following	 molecular	 analyses	 confirmed	 the	 genetic	 deletions.	 FACS	 analysis	
showed	the	double‐KO	phenotype	for	both	antigens	confirming	the	mutated	geno‐




antigens in the diet.
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2.3 | PCR set‐up for identification and validation of 
target genes
Ensemble	database	was	analysed	to	obtain	the	Reference	genome	
sequences	 for	 the	 GGTA1	 (ENSBTAG00000012090)	 and	 of	 the	
CMAH	 (ENSBTAG00000003892)	 genes.	 These	 sequences	 were	
studied	 in	 silico	 to	 identify	possible	 target	 sequences,	 and	 the	 se‐
lected	regions	were	amplified	by	PCR	and	analysed	with	Sanger	se‐
quencing	 to	exclude	polymorphisms	 in	male	 and	 female	 fibroblast	
cell	lines	selected	for	the	genome	editing.








the	 editing	 of	 the	male,	we	 used	one	 guide	 (Table	 2,	 btCMAHcr1)	
and	 subsequently	 for	 the	 female	we	 found	 a	more	 efficient	 guide	
(Table	3,	btCMAHcr2).
Target	exons	and	primers	used	for	PCR	analyses	and	Sanger	se‐
quencing	of	each	gene	are	 summarized	 in	Table	1.	All	 the	 synthe‐
tized	 oligonucleotides	 and	 the	 Sanger	 sequencing	 services	 were	
purchased	from	Eurofins	Genomics,	unless	otherwise	stated.
2.4 | Genomic DNA extraction and PCR conditions
Primary	 fibroblasts	 and	 tissues	 biopsies	 were	 lysed	 at	 55°C	 for	
3	hours	using	a	lysis	buffer	(100	mmol/L	Tris	HCl	pH	8.3,	5	mmol/L	
EDTA	 pH	 8.1,	 0.2%	 SDS,	 200	 mmol/L	 NaCl)	 supplemented	 with	
Proteinase	 K	 (300	 µg/mL;	 Macherey‐Nagel).	 Genomic	 DNA	 was	
extracted	 (Sambrook	et	al,	1989)	and	resuspended	with	TE	buffer.	
All	 the	 amplifications	 were	 performed	 using	 Takara	 La	 Taq	 DNA	
Polymerase	(Takara,	Japan).





TA B L E  2  Oligonucleotides	synthetized	for	the	assembly	of	desired	CRISPR/Cas9	expression	vectors	used	for	the	male	line	and	sequence	
of	the	ssCMAH‐STOP	oligo





btGGTA1cr1	FW CACCGGAGACCCTGGGCGAGTCGG GGAGACCCTGGGCGAGTCGG‐TGG GGTA1	(9) pX330‐btG‐
GTA1cr1btGGTA1cr1	RV AAACCCGACTCGCCCAGGGTCTCC
btGGTA1cr2	FW CACCGCTGGGCCACCGACTCGCCC GCTGGGCCACCGACTCGCCC‐AGG GGTA1	(9) pX330‐btG‐
GTA1cr2btGGTA1cr2	RV AAACGGGCGAGTCGGTGGCCCAGC








Oligo Sequence (5′‐3′) Gene Target exon Amplicon (bp)
FW1 GGATGCCTTTGATAGAGTTGG GGTA1 9 440
RV1 GCTTTCATCATGCCATTGG
FW2 AGCATCTTTCACAACTCAGG GGTA1 4 739
RV2 TGAGACATTAGGAACATGGC
FW3 TCAGGAGGAGACATCACCAACGG CMAH 2 225
RV3 TGCCCATCCTACTTGTCGAGGG
TA B L E  1  Primers	used	for	genotyping	
of	bovine	wild‐type	cell	lines,	edited	
colonies and cloned animals








Determination	 of	 the	 absence	 of	 any	 genomic	 polymorphisms	
was	achieved	cloning	each	resulting	PCR	products	in	E coli using the 
TOPO	TA	cloning	kit	 (Thermo	Fisher	Scientific).	Resulting	purified	
plasmids	 (Plasmid	Mini	 kit,	 Qiagen)	 were	 subjected	 to	 Sanger	 se‐
quencing	analyses	(Eurofins	Genomics).
2.5 | CRISPR/Cas9 plasmid constructs, single 




(sgRNAs),	 into	 the	 pX330‐U6‐Chimeric_BB‐CBh‐hSpCas9	 expres‐





vectors	 (Plasmid	mini	 kit,	 PC‐20,	Qiagen)	were	 verified	 by	 Sanger	
sequencing	before	transfection.
Edited	 female	 colonies	 were	 obtained	 transfecting	 the	 Cas9	
protein/gRNA	 ribonucleoprotein	 complexes	 (Cas9‐RNPs).31,32 
Desired	sgRNAs	(btGGTA1cr3 and btCMAHcr2)	were	in	vitro	syn‐
thetized	 following	 the	 CRISPOR	 guidelines	 (http://crisp	or.org/).	
Briefly,	 oligonucleotides	 (Table	 3)	 were	 annealed,	 amplified	 and	
purified	before	to	use	the	resulting	amplification	product	as	tem‐
plate	(1μg)	for	the	following	transcription	step.	Single	guide	RNAs	
were	 finally	 synthetized	 using	 the	 TranscriptAid	 T7	 High	 Yield	
Transcription	 kit	 (Thermo	 Fisher	 Scientific)	 and	 purified	 on	 sil‐
ica	 membranes	 columns	 (MEGAclear	 Transcription	 clean‐up	 kit,	
Thermo	Fisher	Scientific)	according	to	the	manufacturer's	instruc‐
tions	and	stored	at	−80°C.








2.6 | Culture, transfection and selection of adult 
fibroblasts
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Male	 fibroblasts	 (2	 ×	 106	 cells)	 were	 transfected	 using	
Nucleofector	(V‐024	program,	Lonza),	two	µg	of	each	the	3	CRISPR/
Cas9	 expressing	 vectors	 (pX330‐btGGTA1cr1	 and	 pX330‐btG‐
GTA1cr2—exon9	 of	 GGTA1	 gene;	 pX330‐btCMAHcr1—exon	 2	 of	
CMAH	gene)	and	0.4	nmol	of	the	ssCMAH‐STOP	oligo	(IDT).
Female	 fibroblasts	 (1	×	106	 cells)	were	 transfected	using	Neon	
system	 (P‐9	program;	Thermo	Fisher	Scientific)	and	the	Cas9‐RNP	
complex	format	of	the	S pyogenes.	Cas9‐RNP	was	obtained	mixing	
the	 recombinant	 Cas9	 protein	 (14.4	 μg;	 Edit‐R	 Cas9,	 Dharmacon),	





F I G U R E  1  Editing	of	GGTA1 and CMAH	genes	in	male	and	female	fibroblasts.	A,	Target	sequences	for	selected	sgRNAs	and	ssCMAH‐
STOP	oligo	sequence.	For	each	bovine	gene	(GGTA1 and CMAH),	target	sequences	are	indicated	on	the	respective	exons	recognized	by	the	
selected	sgRNAs.	PAM	sequences	are	highlighted	in	blue.	In	the	ssCMAH‐STOP	oligo	sequence,	the	TAA	(STOP)	codon	is	highlighted	in	
bold character; the AflII	restriction	site	is	underlined.	B,	PCR	analyses	of	female	colonies.	The	results	of	the	PCR	analyses	performed	for	the	
genomic	characterization	of	the	female	colonies	(A1,	A2,	A3,	A4,	A5	and	A6)	selected	after	Dynabeads	sorting	are	reported	as	an	example.	
Each	colony	was	analysed	for	the	GGTA1	gene	(739	bp)	and	for	the	CMAH	gene	(225	bp).	Resulting	electrophoretic	patterns	determined	
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biotin‐conjugated	 IB4	 lectin	 attached	 to	 streptavidin‐coated	 mag‐
netic beads.33‐35	Cells	were	harvested	(6.5	×	106	cells)	and	suspended	





nies with good morphology were picked up and expanded.
For	 each	 colony,	 one	 aliquot	was	 cryopreserved	 in	 liquid	 ni‐
trogen	 (DMEM/TCM199	1:1,	20%	FBS	and	10%	DMSO)	for	sub‐







detecting the occurred Indels	and	the	successful	ssCMAH‐STOP	oli‐
gonucleotide	knock‐in	events.
Eight	(four	male	and	four	female)	confirmed	DKO	colonies,	edited	





were done using the same materials and methods described above.
2.7 | Somatic cell nuclear transfer (SCNT)
The	protocol	used	is	described	in	Galli	et	al36	with	minor	modifica‐
tions.	Briefly,	the	bovine	ovaries	were	collected	at	a	local	abattoir.	








cells	 were	 induced	 into	 quiescence	 by	 serum	 starvation	 (0.5%	
FCS).	 The	 day	 of	 SCNT,	 cells	were	 trypsinized	 and	 resuspended	
in	H‐SOF37	buffered	with	25	mmol/L	Hepes	(H‐SOF)	used	for	all	





cleated	 oocytes.	 Donor	 cell‐cytoplast	 couplets	 were	 washed	 in	




of	 incubation	 in	 mSOF	 medium	 supplemented	 with	 1	 mmol/L	
6‐DMAP	and	5	μg/mL	cycloheximide.	At	the	end	of	the	activation,	
reconstructed	 embryos	 were	 cultured	 in	 mSOF	 supplemented	
with	essential	and	non‐essential	amino	acids	and	4	mg/mL	BSA	up	
to	7‐8	days	to	the	blastocyst	stage.
2.8 | Recipients synchronization, embryo transfer 
(ET) and calving
Heifers	of	14‐16	months	of	age	were	used	as	recipients.	Oestrus	was	
synchronized	using	 the	Ovsynch	protocol	with	 two	 injections	of	a	
GnRH	analogue	 (Dalmarelin,	Fatro,	 Italy)	8	days	apart.	Forty‐eight	
hours	after	the	second	injection,	animals	were	observed	for	oestrus	
signs and 6 days later those that showed oestrus were ultrasound 
scanned	to	detect	the	presence	of	a	corpus	luteum	(CL).	Those	that	
had	a	well‐developed	CL	 received	1	or	2	embryos	 (either	 fresh	or	
frozen	thawed)	by	non‐surgical	ET	ipsilateral	to	the	CL.	Four	weeks	
after	ET,	 pregnancy	diagnosis	was	performed	by	ultrasound	 scan‐
ning and then the pregnant animals were checked at monthly inter‐
val	till	the	end	of	the	pregnancy.	The	delivery	of	the	calves	was	by	
elective	caesarean	section	at	280	days	of	gestation.
2.9 | Genotyping and phenotyping analyses for 
αGal and Neu5Gc antigens in DKO cattle‐derived 
primary cells
Newborn	calves	were	subjected	to	ear	biopsy	to	establish	a	primary	
cell	 line,	 to	 extract	 the	 genomic	DNA	 for	 genotyping	by	PCR	 and	
DNA	sequencing	as	described	above.	Resulting	primary	fibroblasts	
for	each	calf	were	expanded	and	cryopreserved	in	DMEM:TCM199	
1:1	with	10%	DMSO	and	20%	FCS	 in	CBS	straws	 (IMV,	 Italy).	For	
FACS	 analysis,	 bovine	 fibroblasts	 were	 thawed	 and	 cultured	 in	
DMEM	medium	(Gibco),	with	10%	FBS,	1%	Peni‐Strepto	and	bFGF	
(Sigma,	 1	 ng/mL).	Once	 confluent,	 cells	were	 trypsinized	 and	 split	
into	two	culture	dishes,	one	with	the	complete	medium	as	above	and	
the	other	with	DMEM	medium,	5%	human	serum	(Sigma),	1%	Peni/
strepto	 and	 bFGF	 (1	 ng/mL).	 For	 αGal	 analysis,	 cells	 were	 trypsi‐
nized,	resuspended	and	washed	in	PBS	+	BSA	0.1%.	The	cells	were	
pelleted	(750g	x	1	minute,	4°C)	and	resuspended	in	PBS	+	BSA	0.1%	
containing	 the	FITC	coupled	 lectin	 (BS‐I	 Isolectin	B4)	diluted	1:50	







human	serum.	Cells	were	seeded	 in	96‐well	plates	 (106	 cells/well),	
washed	 once	 with	 PBS	 with	 0.5%	 fish	 gelatin	 (PBS‐FG)	 and	 then	
incubated	 in	 200	 µL	 PBS‐FG	 with	 anti‐Neu5Gc	 antibody	 or	 con‐
trol	 isotype	 (BioLegend,	 chicken	 polyclonal	 IgY,	 dilution	 1	 :1000)	
for	 1	 hour	 at	 4°C,	 washed	 four	 times	 in	 PBS‐FG,	 incubated	 in	
100	µL	PBS‐FG	with	Alexa	647‐coupled	anti‐IgY	antibody	(Jackson	
ImmunoResearch,	 F(ab′)2	 fragment	donkey	 anti‐chicken	1:500)	 for	
     |  7 of 13PEROTA ET Al.





of	Neu5Gc	due	 to	 culture	 conditions	 and	often	 some	background	
staining remains like the one observed in Figure 4.
3  | RESULTS
3.1 | Disruption of GGTA1 and CMAH genes in 
primary bovine fibroblast lines
Two	 millions	 male	 fibroblasts	 were	 nucleofected	 and	 expanded	
for	7	days	to	6.5	×	106.	After	Dynabeads	sorting,	4200	αGal‐nega‐
tive	 cells	 (0.065%)	were	 recovered	 and	 plated	 in	 20	 Petri	 dishes	
(∅	=	150	mm)	for	clonal	selection.	Ten	days	after	plating,	41	(1%)	
best	growing	colonies	were	picked	up	for	PCR	analysis	and	SCNT.	
Editing	 of	 the	 female	 fibroblasts	 took	 place	 a	 year	 later,	 and	we	
used	a	different	system	using	neon	transfection	with	the	Cas9	pro‐
tein	for	the	first	time.	From	the	one	million	female	fibroblasts	trans‐






and AflII‐RFLP	 analyses	 revealed	 that	 15	 appeared	 to	 be	 edited	
for	the	CMAH	gene	and	for	this	reason	they	were	sent	for	Sanger	
sequencing	analyses	of	 their	GGTA1 and CMAH	 genes	 (Figure	1C	
and	Table	S1).	GGTA1‐KO	was	confirmed	in	all	15	colonies	and	13	
(31.7%)	resulted	also	KO	for	Neu5Gc	(Table	4).
The	 female	 colonies	were	 subjected	 to	 the	 same	analysis.	 The	
PCR	 analysis	 (Figure	 1B)	 followed	 by	 Sanger	 sequencing	 analyses	
(Figure	1C	and	Table	S1)	on	both	genes	of	 the	six	 female	colonies	
revealed	 that	 two	 colonies	were	 heterozygotes	 and	 four	 colonies	
were	KO	(66.6%)	for	the	CMAH gene and that all six colonies were 
F I G U R E  2  DKO	calves	and	sequencing	results.	A,	Pictures	of	cloned	DKO	calves.	Two	healthy	cloned	bull	calves	(9161	and	9162)	were	
generated	from	two	different	DKO	colonies	(A4	and	E3).	Cloned	heifer	calf	was	generated	using	the	colony	A6.	B,	Sequencing	results	for	
9161. For the GGTA1	gene,	it	was	confirmed	that	this	gene	is	affected	by	two	different	deletions	(21	and	171	bp),	as	previously	described	for	
the	edited	colony	A4	(Table	S1).	These	data	were	finally	demonstrated	by	the	deletion	(17	bp)	generated	in	the	CMAH	gene.	C,	Sequencing	
results	for	9162.	The	GGTA1	gene	sequence	presented	a	8	bp	deletion,	and	the	CMAH	gene	is	characterized	by	the	same	2	different	




8 of 13  |     PEROTA ET Al.
(A)
(B)
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GGTA1‐KO	 (Table	4),	 confirming	 the	high	 efficiency	of	Dynabeads	
selection	for	the	GGTA1	KO.
Male	A4	and	E3	and	female	A6	colonies	were	used	for	SCNT	based	




3.2 | Generation of DKO calves by SCNT
Two	male	 DKO	 colonies	 (A4	 and	 E3)	 were	 used	 as	 nuclear	 do‐
nors	 for	 SCNT	 (Table	 5).	 Seven	 blastocysts	 (BLs),	 derived	 from	
colony	A4,	were	transferred	in	5	synchronized	recipients,	4	(80%)	





Female	DKO	 colony	A6	was	 used	 for	 SCNT,	 and	 31	BLs	were	
transferred	in	16	recipients;	6	(37.5%)	became	pregnant	and	1	preg‐
nancy	went	to	term	delivering	1	calf	(9163,	Figure	2A).
3.3 | Genotyping of cloned calves
Sanger	 sequencing	 of	 TOPO	 TA‐cloned	 PCR	 products	 of	 DKO	
calves	 confirmed	 the	 Indels	 characterizing	 the	 colonies	 used	 for	
cloning.	In	details,	in	clone	9161,	GGTA1	gene	is	affected	by	two	dif‐
ferent	mutations	 in	exon	9	 (del	AGACCCTGGGCGAGTCGGTGG/
del	 171bp)	 and	 the	 exon	2	of	 the	CMAH gene carries a deletion 
(del	 GGCAGGCAAGTGAGGGA)	 as	 it	 was	 described	 for	 colony	
A4	(Table	S1;	Figure	2B).	 In	clone	9162	(Figure	2A),	a	deletion	 in	
GGTA1	gene	(del	AGTCGGTG)	is	accompanied	by	2	different	mu‐
tations	 in	 the	 exon	2	 of	CMAH	 gene.	 The	 first	 allele	was	 inacti‐
vated	by	the	substitution	of	the	ATG	codon	(START)	with	the	TAA	
codon	 (STOP),	due	to	 the	homology‐directed	repair	 (HDR)	event	
driven by the ssCMAH‐STOP	 oligo,	 as	 described	 for	 colony	 E3	
(Table	S1,	Figure	2C),	and	the	second	allele	has	13	bp	deletion	(del	
AGGCAAGTGAGGG).
Sanger	 sequencing	 results	 of	 female	 clone	 9163	 (Figure	 2A)	
demonstrated	that	a	deletion	in	the	exon	4	of	the	GGTA1	gene	(del	
54bp)	and	the	substitution	of	the	START	to	a	STOP	codon	(ATG		TAA)	
in	the	exon	2	of	the	CMAH gene are identical to the Indels described 




3.4 | Phenotyping of cloned calves
FACS	analysis	confirmed	the	genotyping	results	of	the	three	calves.	
All	primary	cell	lines	derived	from	biopsies	of	the	cloned	male	calves	









we	 can	 conclude	 that	 the	 tail	 of	Neu5Gc	 staining	 is	 background	
staining	 coming	 from	 the	different	 experimental	 setting	 and	 cul‐
ture conditions.
4  | DISCUSSION








modified	 pigs	 and	 the	 consequent	 generation	 of	 animal	 models	













ough	 screening	of	 the	 few	 colonies	 selected	 and	 the	 combination	
with	SCNT,	we	were	able	to	generate	DKO	male	and	female	calves.	
All	 the	bovine	genome	editing	work	was	undertaken	to	disrupt	si‐






We	selected	to	target	exon	9	of	GGTA1 gene in the male line 
using	 together	 two	 different	 sgRNAs	 (btGGTA1cr1 and btGG‐
TA1cr2—Figure	 1A).	 In	 contrast	 to	 the	 female	 line,	 we	 targeted	
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scribed	 for	 the	pig	by	 Li	 et	 al.38	The	use	of	 ssODN‐mediated	KI	






















that	were	 gestated	by	WT	 surrogate	mother	 and	 fed	 after	 birth	











conditions;	 on	 the	 other	 end,	 also	 the	male	 cells	 used	 as	 nega‐
tive control that was completely clear in a previous experiment 
(Figure	3B)	had	the	same	right	shift	 for	Neu5Gc	 (Figure	4B).	We	
can	conclude	that	the	generation	of	DKO	cattle	 is	possible	using	
the	 latest	 genome	 editing	 technologies	 combined	 with	 SCNT.	
This	will	 offer	 the	 opportunity	 to	 use	 novel	 biological	materials	
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TA B L E  4   Fibroblasts colonies—screening results
Bovine line Picked colonies GGTA1‐KO (beads)
CMAH‐KO 
(PCR + RFLP) GGTA1‐KO (sequencing) CMAH‐KO (sequencing)
Male 41 41 15 15 13
Female 6 6 6 6 4
TA B L E  5  Development	of	cloned	embryos	after	transfer	into	recipient	heifers
Bovine line No. of colonies No. of embryos No. of recipients No. of pregnant (%)
No. of born 
alive at term
Male A4 7 5 4	(80) 1
Male E3 15 12 5	(41.6) 1
Female A6 31 16 6	(37.5) 1
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